(Q44861647)

English

Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine

scientific article published in February 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Listeria monocytogenes

0 references

feline immunodeficiency virus

object named as

feline immunodeficiency virus

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

Rosemary Stevens

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Alora Lavoy

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Shila Nordone

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Maryjo Burkhard

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

0 references

publication date

1 February 2005

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1479-1490

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Dendritic cells are early cellular targets of Listeria monocytogenes after intestinal delivery and are involved in bacterial spread in the host.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Human dendritic cells infected by Listeria monocytogenes: induction of maturation, requirements for phagolysosomal escape and antigen presentation capacity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Differences in interleukin-12 and -15 production by dendritic cells at the early stage of Listeria monocytogenes infection between BALB/c and C57 BL/6 mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Listeria monocytogenes-infected human dendritic cells: uptake and host cell response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Immunity to intracellular bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Specific Lyt 123 cells are involved in protection against Listeria monocytogenes and in delayed-type hypersensitivity to listerial antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Specific lysis of Listeria monocytogenes-infected macrophages by class II-restricted L3T4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Recombinant Listeria monocytogenes as a live vaccine vehicle and a probe for studying cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Nonsecreted bacterial proteins induce recall CD8 T cell responses but do not serve as protective antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Anti-human immunodeficiency virus-gag CD8+ memory T cells generated in vitro from Listeria-immunized mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

FIV infection of the domestic cat: an animal model for AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

FIV vaccine development and its importance to veterinary and human medicine: a review FIV vaccine 2002 update and review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Perspectives on FIV vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

SIV and FIV vaccine studies at UC Davis: 1991 update

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Tenth anniversary perspectives on AIDS. FIV as a model for AIDS vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

High-efficiency transformation of Listeria monocytogenes by electroporation of penicillin-treated cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Restriction maps of plasmids pUB110 and pBD9

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Integration of PCR fragments at any specific site within cloning vectors without the use of restriction enzymes and DNA ligase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Feline immunodeficiency virus Gag- and Env-specific immune responses after vaginal versus intravenous infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Oral immunization with recombinant listeria monocytogenes controls virus load after vaginal challenge with feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Engineered Listeria monocytogenes as an AIDS vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Vaginal and rectal infection of cats with feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Mucosally transmitted feline immunodeficiency virus induces a CD8+ antiviral response that correlates with reduction of cell-associated virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

The CD8+ cell phenotype mediating antiviral activity in feline immunodeficiency virus-infected cats is characterized by reduced surface expression of the CD8 beta chain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Mucosal transmission of cell-associated and cell-free feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Progressive expansion of an L-selectin-negative CD8 cell with anti-feline immunodeficiency virus (FIV) suppressor function in the circulation of FIV-infected cats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

The cat/feline immunodeficiency virus model for transmucosal transmission of AIDS: nonoxynol-9 contraceptive jelly blocks transmission by an infected cell inoculum.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Feline immunodeficiency virus clade C mucosal transmission and disease courses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Relationship of lymphoid lesions to disease course in mucosal feline immunodeficiency virus type C infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Vaccines and the induction of functional antibodies: time to look beyond the molecules of natural infection?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Interactions of polyclonal and monoclonal anti-glycoprotein 120 antibodies with oligomeric glycoprotein 120-glycoprotein 41 complexes of a primary HIV type 1 isolate: relationship to neutralization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

gp120: Biologic aspects of structural features

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Epitope exposure on functional, oligomeric HIV-1 gp41 molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Eukaryotic expression plasmid transfer from the intracellular bacterium Listeria monocytogenes to host cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

DNA-immunization with a V2 deleted HIV-1 envelope elicits protective antibodies in macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

Antigen-specific T-cell responses during primary and secondary Listeria monocytogenes infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

based on heuristic

inferred from DOI database lookup

Nucleotide sequence and functional map of pE194, a plasmid that specifies inducible resistance to macrolide, lincosamide, and streptogramin type B antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.033

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2004.09.033

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44861647&oldid=2054216165"